An interesting aspect to highlight that reinforces the previous assumption is the significant difference (p = 0.0001) between the mean ALT value in the studies of patients with NAFLD (25.3 ± 19.5 IU/L) compared that of the studies of patients with chronic hepatitis (72.49 ± 167.82 IU/L). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.